These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35169039)

  • 1. Principles for Management of Extractables and Leachables in Ophthalmic Drug Products.
    Houston CT; Rodrigues AD; Smith BB; Wang T; Richardson M
    PDA J Pharm Sci Technol; 2022; 76(3):278-294. PubMed ID: 35169039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
    Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
    PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
    Norwood DL; Nagao LM; Stults CL
    PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
    Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
    PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extractables characterization for five materials of construction representative of packaging systems used for parenteral and ophthalmic drug products.
    Jenke D; Castner J; Egert T; Feinberg T; Hendricker A; Houston C; Hunt DG; Lynch M; Shaw A; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F
    PDA J Pharm Sci Technol; 2013; 67(5):448-511. PubMed ID: 24084660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations.
    Norwood DL; Paskiet D; Ruberto M; Feinberg T; Schroeder A; Poochikian G; Wang Q; Deng TJ; DeGrazio F; Munos MK; Nagao LM
    Pharm Res; 2008 Apr; 25(4):727-39. PubMed ID: 18183477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Framework for sensitization assessment of extractables and leachables in pharmaceuticals.
    Parris P; Whelan G; Burild A; Whritenour J; Bruen U; Bercu J; Callis C; Graham J; Johann E; Griffin T; Kohan M; Martin EA; Masuda-Herrera M; Stanard B; Tien E; Cruz M; Nagao L
    Crit Rev Toxicol; 2022 Feb; 52(2):125-138. PubMed ID: 35703156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.
    Jenke D
    PDA J Pharm Sci Technol; 2023; 77(4):329-338. PubMed ID: 37001885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
    Parris P; Martin EA; Stanard B; Glowienke S; Dolan DG; Li K; Binazon O; Giddings A; Whelan G; Masuda-Herrera M; Bercu J; Broschard T; Bruen U; Callis CM; Stults CLM; Erexson GL; Cruz MT; Nagao LM
    Regul Toxicol Pharmacol; 2020 Dec; 118():104802. PubMed ID: 33038429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls).
    Masuda-Herrera M; Rosen HT; Burild A; Broschard T; Bell T; Graham J; Griffin T; Hillegass J; Leavitt P; Huta B; Parris P; Bruen U; Cruz M; Bercu J
    Regul Toxicol Pharmacol; 2023 Dec; 145():105494. PubMed ID: 37748702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Safety Risk-Based Extractables and/or Leachables Qualification Strategy for Packaged Drug Products.
    Jenke D
    PDA J Pharm Sci Technol; 2021; 75(6):506-535. PubMed ID: 33990423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extractables and leachables considerations for prefilled syringes.
    Jenke DR
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1591-600. PubMed ID: 24955780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective.
    Markovic I
    Expert Opin Drug Saf; 2007 Sep; 6(5):487-91. PubMed ID: 17877437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and quantification of extractables and leachables in laminated film and pouches for pharmaceutical packaging.
    Fu C; Zhang X; Lei S; Zou M; Wang L; Jiao J; Yang Q
    J Pharm Biomed Anal; 2022 Oct; 220():115015. PubMed ID: 36054946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - Current challenges and approaches.
    Broschard TH; Glowienke S; Bruen US; Nagao LM; Teasdale A; Stults CL; Li KL; Iciek LA; Erexson G; Martin EA; Ball DJ
    Regul Toxicol Pharmacol; 2016 Nov; 81():201-211. PubMed ID: 27569203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell and Gene Therapies: Challenges in Designing Extractables and Leachables Studies and Conducting Safety Assessments.
    Arroyo A; Booij P; Woldemariam G; Bruen U; Creasey J; Stanard B; Parris P; Nagao L; Bielinski MK
    J Pharm Sci; 2024 Mar; 113(3):513-522. PubMed ID: 38176455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mass spectrometry and related techniques in the analysis of extractable and leachable chemicals.
    Sica VP; Krivos KL; Kiehl DE; Pulliam CJ; Henry ID; Baker TR
    Mass Spectrom Rev; 2020 Mar; 39(1-2):212-226. PubMed ID: 30921495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Extractables and Leachables Chemical Space to Support In Silico Toxicological Hazard Assessments.
    Johnson C; Bassan A; Kiehl D; Paskiet D; Pavan M; Parris P; Whelan G; Burild A; Myatt GJ
    PDA J Pharm Sci Technol; 2024 Jun; 78(3):237-311. PubMed ID: 38942479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.